» Articles » PMID: 39456731

Deciphering the Complexity of FSHD: A Multimodal Approach As a Model for Rare Disorders

Abstract

Rare diseases are heterogeneous diseases characterized by various symptoms and signs. Due to the low prevalence of such conditions (less than 1 in 2000 people), medical expertise is limited, knowledge is poor and patients' care provided by medical centers is inadequate. An accurate diagnosis is frequently challenging and ongoing research is also insufficient, thus complicating the understanding of the natural progression of the rarest disorders. This review aims at presenting the multimodal approach supported by the integration of multiple analyses and disciplines as a valuable solution to clarify complex genotype-phenotype correlations and promote an in-depth examination of rare disorders. Taking into account the literature from large-scale population studies and ongoing technological advancement, this review described some examples to show how a multi-skilled team can improve the complex diagnosis of rare diseases. In this regard, Facio-Scapulo-Humeral muscular Dystrophy (FSHD) represents a valuable example where a multimodal approach is essential for a more accurate and precise diagnosis, as well as for enhancing the management of patients and their families. Given their heterogeneity and complexity, rare diseases call for a distinctive multidisciplinary approach to enable diagnosis and clinical follow-up.

References
1.
Lemmers R, van der Vliet P, Klooster R, Sacconi S, Camano P, Dauwerse J . A unifying genetic model for facioscapulohumeral muscular dystrophy. Science. 2010; 329(5999):1650-3. PMC: 4677822. DOI: 10.1126/science.1189044. View

2.
Hamanaka K, Sikrova D, Mitsuhashi S, Masuda H, Sekiguchi Y, Sugiyama A . Homozygous nonsense variant in associated with facioscapulohumeral muscular dystrophy. Neurology. 2020; 94(23):e2441-e2447. PMC: 7455367. DOI: 10.1212/WNL.0000000000009617. View

3.
Giardina E, Mandich P, Ghidoni R, Ticozzi N, Rossi G, Fenoglio C . Distribution of the hexanucleotide repeat expansion in healthy subjects: a multicenter study promoted by the Italian IRCCS network of neuroscience and neurorehabilitation. Front Neurol. 2024; 15:1284459. PMC: 10865370. DOI: 10.3389/fneur.2024.1284459. View

4.
Caputo V, Megalizzi D, Fabrizio C, Termine A, Colantoni L, Bax C . Methylation Levels Combined with a Machine Learning Pipeline Highlight Single CpG Sites as Discriminating Biomarkers for FSHD Patients. Cells. 2022; 11(24). PMC: 9777431. DOI: 10.3390/cells11244114. View

5.
Wohlgemuth M, Lemmers R, Jonker M, van der Kooi E, Horlings C, van Engelen B . A family-based study into penetrance in facioscapulohumeral muscular dystrophy type 1. Neurology. 2018; 91(5):e444-e454. PMC: 6093768. DOI: 10.1212/WNL.0000000000005915. View